{"id":538489,"date":"2021-09-15T08:04:28","date_gmt":"2021-09-15T12:04:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/"},"modified":"2021-09-15T08:04:28","modified_gmt":"2021-09-15T12:04:28","slug":"krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/","title":{"rendered":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe"},"content":{"rendered":"
\n

PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc.<\/a>, (\u201cKrystal\u201d) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has more than 20 years of global biotechnology experience, including serving as the Head of Global Strategic Marketing and Market Access at Galderma.<\/p>\n

\u201cWe are excited to welcome Laurent to the Krystal team at such a pivotal time for our lead investigational program, B-VEC for DEB, and the rest of our growing rare disease pipeline,\u201d said Andy Orth, Chief Commercial Officer of Krystal Biotech. \u201cHe is an accomplished executive who has successfully launched several medicines and aesthetic brands across many countries. He will lead the development of Krystal\u2019s commercial capabilities in the European Region as we work towards our goal of building a fully integrated biotechnology company.\u201d<\/p>\n

In his latest role as Head of Global Strategic Marketing and Market Access at Galderma, Laurent led the global commercial organization through multiple successes and launches of dermatologic disease medicines. He was responsible for leading the Global Market Access, Pricing, HEOR and Strategic Marketing. Previously, Laurent served as Galderma\u2019s Regional Director EMEA-Emerging Markets, where he led regional commercial development, opened several new markets and managed multiple partners. Prior to that, Laurent held various roles across General Management, Business Development and Finance with Galderma and Arthur Andersen. Laurent is an Engineer in Physics and Chemistry, and holds Master\u2019s degrees in Organic Chemistry from Bordeaux University and in Strategy and Management of International Business from the ESSEC Business School.<\/p>\n

\u201cI am delighted to be part of a dedicated team focused on developing novel treatments for debilitating rare diseases,\u201d Laurent commented. \u201cKrystal\u2019s redosable gene delivery platform shows great promise, and I look forward to setting up operations in Europe with the goal of bringing important medicines to patients in need.\u201d<\/p>\n

\n
\n About\u00a0Krystal Biotech<\/em>
\n <\/strong>
\n
Krystal Biotech, Inc.\u00a0(NASDAQ:KRYS) is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases. For more information, please visit\u00a0http:\/\/www.krystalbio.com<\/a>.<\/p>\n\n\n\n\n\n\n\n
\n CONTACTS:<\/strong>\n <\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Investors:<\/strong>\n <\/td>\n\n Media:<\/strong>\n <\/td>\n<\/tr>\n
Whitney Ijem<\/td>\nMary Coyle<\/td>\n<\/tr>\n
Krystal Biotech<\/td>\nTellMed Strategies<\/td>\n<\/tr>\n
wijem@krystalbio.com<\/td>\nmary.coyle@tmstrat.com<\/td>\n<\/tr>\n<\/table>\n

Source: Krystal Biotech, Inc.<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (\u201cKrystal\u201d) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has more than 20 years of global biotechnology experience, including serving as the Head of Global Strategic Marketing and Market Access at Galderma. \u201cWe are excited to welcome Laurent to the Krystal team at such a pivotal time for our lead investigational program, B-VEC for DEB, and the rest of our growing rare disease pipeline,\u201d said Andy Orth, Chief Commercial Officer of Krystal Biotech. \u201cHe is an accomplished executive who has successfully launched several medicines and aesthetic brands across many countries. He will … <\/p>\n

Continue reading “Krystal Biotech Appoints Laurent Goux as General Manager of Europe”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538489","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKrystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Krystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (\u201cKrystal\u201d) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has more than 20 years of global biotechnology experience, including serving as the Head of Global Strategic Marketing and Market Access at Galderma. \u201cWe are excited to welcome Laurent to the Krystal team at such a pivotal time for our lead investigational program, B-VEC for DEB, and the rest of our growing rare disease pipeline,\u201d said Andy Orth, Chief Commercial Officer of Krystal Biotech. \u201cHe is an accomplished executive who has successfully launched several medicines and aesthetic brands across many countries. He will … Continue reading "Krystal Biotech Appoints Laurent Goux as General Manager of Europe"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T12:04:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Krystal Biotech Appoints Laurent Goux as General Manager of Europe\",\"datePublished\":\"2021-09-15T12:04:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/\",\"name\":\"Krystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=\",\"datePublished\":\"2021-09-15T12:04:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Krystal Biotech Appoints Laurent Goux as General Manager of Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/","og_locale":"en_US","og_type":"article","og_title":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk","og_description":"PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (\u201cKrystal\u201d) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has more than 20 years of global biotechnology experience, including serving as the Head of Global Strategic Marketing and Market Access at Galderma. \u201cWe are excited to welcome Laurent to the Krystal team at such a pivotal time for our lead investigational program, B-VEC for DEB, and the rest of our growing rare disease pipeline,\u201d said Andy Orth, Chief Commercial Officer of Krystal Biotech. \u201cHe is an accomplished executive who has successfully launched several medicines and aesthetic brands across many countries. He will … Continue reading \"Krystal Biotech Appoints Laurent Goux as General Manager of Europe\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T12:04:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe","datePublished":"2021-09-15T12:04:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/","name":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=","datePublished":"2021-09-15T12:04:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTc2MSM0NDA0NzI0IzIwOTE5Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/krystal-biotech-appoints-laurent-goux-as-general-manager-of-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Krystal Biotech Appoints Laurent Goux as General Manager of Europe"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538489"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538489\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}